We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 40,218

Employee Remuneration for Service Inventions: Collective Regulation may Help Reduce the Exposure of R&D Companies
  • S Horowitz & Co
  • Israel
  • August 17 2017

A recent precedential decision, issued by the Compensation and Royalties Committee ("the Committee"), in a case in which our firm represented a

Savvy food companies beef up their IP protection for vegan products
  • Barker Brettell LLP
  • United Kingdom
  • August 17 2017

There’s a veggie-driven revolution going on in the food industry right now. Led by customer demand for meat alternatives (the number of vegans in

Expedited examination fast-tracks patent grants in India
  • LexOrbis
  • India
  • August 17 2017

The grant of a patent in India usually takes a time period of 3-4 years or more. Normally, the process of grant for a patent involves a major ladder

Post-Grant Amendments from Method of Treatment to Swiss-Style - The Singapore Position
  • Mirandah Asia
  • Singapore
  • August 17 2017

In the landmark case of Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd 2017 SGCA 45, the Singapore Court of Appeal explored, inte

The Impact of Biosimilars on Global Pharmaceutical Markets
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • August 17 2017

Biologic drugs are quickly reshaping the pharmaceutical landscape as they dominate the drug market in annual sales revenue. AbbVie’s Humira

China seeks to streamline patent filings
  • Novagraaf
  • China
  • August 17 2017

The State Intellectual Property Office (SIPO) of the People's Republic of China has introduced new rules to streamline patent applications and to

Consulta Pública en Brasil
  • Clarke Modet & Co
  • Brazil
  • August 17 2017

Durante el mes de agosto, Brasil mantendrá abierta una consulta pública para evaluar una nueva propuesta de regulación para el procedimiento de

FRAND with benefits
  • Kilburn & Strode LLP
  • United Kingdom
  • August 17 2017

In the recent Unwired Planet v Huawei decision, renowned High Court judge Sir Colin Birss stepped into the standards patents fray and knocked some

Biosimilars in the US: the next frontier for big pharma
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • August 17 2017

The market for biological drug products is forecast to reach a global value of $400bn per year by 2025. Major pharmaceutical companies are investing